GO
| HSI1 | 24,992.49 | +136.06 | 213.60B |
| HSCEI1 | 8,470.26 | +80.33 | 70.87B |
| Back Zoom + Zoom - Block Traded | |
|
2026-03-27 00:19:02 AKESO (09926.HK) announced its 2025 annual results, reporting revenue of RMB30.56 billion, an increase of 43.9% year-on-year. Gross profit reached RMB24.04 billion, up by 31%. The loss expanded from RMB5.15 billion in the previous year to RMB11.13 billion, primarily due to an increase of RMB2.56 billion in impairment losses on equity investments in Summit Therapeutics and an increase of RMB3.87 billion in R&D expenses. The loss per share was RMB1.23. No final dividend was declared. (de/d)~ AASTOCKS Financial News Website: www.aastocks.com | |